FIS

FCPM III Services Portfolio holdings

AUM $369M
1-Year Est. Return 29.21%
This Quarter Est. Return
1 Year Est. Return
-29.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$369M
AUM Growth
-$44.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

1
+$3.45M
2
+$1.62M

Top Sells

1
+$5.49M

Sector Composition

1 Healthcare 99.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$4.1B
$193M 52.16%
10,632,113
-303,197
DYN icon
2
Dyne Therapeutics
DYN
$2.33B
$52M 14.09%
5,462,846
REPL icon
3
Replimune Group
REPL
$351M
$36.3M 9.84%
3,909,696
ENGN icon
4
enGene Holdings
ENGN
$479M
$35.1M 9.5%
9,632,561
BCYC
5
Bicycle Therapeutics
BCYC
$566M
$24M 6.5%
3,452,330
ATXS icon
6
Astria Therapeutics
ATXS
$676M
$23.4M 6.34%
4,107,537
+285,000
RAPT icon
7
RAPT Therapeutics
RAPT
$485M
$3.45M 0.93%
+440,176
ENGNW icon
8
enGene Holdings Warrants
ENGNW
$25.8M
$2.36M 0.64%
2,878,148